[S-4] Bunge Global SA Business Combination Registration
Hagerty, Inc. (HGTY) — Form 144 filing dated 10 July 2025
Robert I. Kauffman, acting through Aldel LLC, filed a Form 144 giving notice of intent to sell 41,239 common shares of Hagerty, Inc. on or about 07/10/2025. At the 07/09/2025 closing price implied by the filing, the transaction is valued at $416,514 and represents roughly 0.05 % of the company’s 90.7 million shares outstanding. The proposed sale will be executed through Merrill Lynch on the NYSE.
The filing also discloses extensive insider activity over the prior three-month period: Kauffman/Aldel sold ≈542,700 shares for ≈$5.35 million in gross proceeds between 24 April and 09 July 2025. While these dispositions equate to only about 0.6 % of shares outstanding, they may signal continued, methodical reduction of the filer’s position following the 2021 business-combination PIPE in which Aldel acquired 3.5 million shares.
No operational or earnings data accompany the notice—Form 144 is strictly a disclosure of a planned sale. Investors typically monitor such filings to gauge insider sentiment and potential supply overhang. Given the modest size relative to Hagerty’s float, immediate price impact is expected to be limited; nevertheless, the cumulative selling trend could weigh on sentiment if it persists.
Hagerty, Inc. (HGTY) — Deposito del Modulo 144 datato 10 luglio 2025
Robert I. Kauffman, tramite Aldel LLC, ha presentato un Modulo 144 notificando l’intenzione di vendere 41.239 azioni ordinarie di Hagerty, Inc. intorno al 10/07/2025. Al prezzo di chiusura del 09/07/2025 indicato nel deposito, la transazione ha un valore di circa 416.514 $ e rappresenta circa lo 0,05% delle 90,7 milioni di azioni in circolazione della società. La vendita sarà effettuata tramite Merrill Lynch alla NYSE.
Il deposito rivela inoltre un’intensa attività interna negli ultimi tre mesi: Kauffman/Aldel ha venduto circa 542.700 azioni per un ricavo lordo di circa 5,35 milioni di $ tra il 24 aprile e il 09 luglio 2025. Sebbene queste vendite rappresentino solo circa lo 0,6% delle azioni in circolazione, potrebbero indicare una riduzione continua e metodica della posizione del depositante dopo la PIPE di combinazione aziendale del 2021, in cui Aldel ha acquisito 3,5 milioni di azioni.
Il Modulo 144 non include dati operativi o sugli utili, essendo esclusivamente una comunicazione di vendita pianificata. Gli investitori monitorano questi depositi per valutare il sentiment interno e l’eventuale pressione di offerta. Considerata la dimensione modesta rispetto al flottante di Hagerty, l’impatto immediato sul prezzo dovrebbe essere limitato; tuttavia, la tendenza cumulativa alla vendita potrebbe influenzare il sentiment se dovesse continuare.
Hagerty, Inc. (HGTY) — Presentación del Formulario 144 con fecha 10 de julio de 2025
Robert I. Kauffman, actuando a través de Aldel LLC, presentó un Formulario 144 notificando su intención de vender 41.239 acciones ordinarias de Hagerty, Inc. alrededor del 10/07/2025. Al precio de cierre del 09/07/2025 indicado en la presentación, la transacción tiene un valor aproximado de 416.514 $ y representa aproximadamente el 0,05% de las 90,7 millones de acciones en circulación de la compañía. La venta se realizará a través de Merrill Lynch en la NYSE.
La presentación también revela una actividad interna intensa durante los últimos tres meses: Kauffman/Aldel vendió aproximadamente 542.700 acciones por unos ingresos brutos de 5,35 millones de $ entre el 24 de abril y el 09 de julio de 2025. Aunque estas disposiciones representan solo cerca del 0,6% de las acciones en circulación, podrían indicar una reducción continua y metódica de la posición del declarante tras la PIPE de combinación empresarial de 2021, en la que Aldel adquirió 3,5 millones de acciones.
El Formulario 144 no incluye datos operativos ni de ganancias, ya que es únicamente una divulgación de una venta planificada. Los inversores suelen monitorear estas presentaciones para evaluar el sentimiento interno y la posible presión de oferta. Dada la modesta dimensión en relación con el flotante de Hagerty, se espera que el impacto inmediato en el precio sea limitado; sin embargo, la tendencia acumulativa de ventas podría afectar el sentimiento si persiste.
Hagerty, Inc. (HGTY) — 2025년 7월 10일자 Form 144 제출
Robert I. Kauffman이 Aldel LLC를 통해 약 2025년 7월 10일경에 Hagerty, Inc.의 41,239 보통주를 매도할 의사를 알리는 Form 144를 제출했습니다. 제출서에 명시된 2025년 7월 9일 종가 기준으로 이 거래의 가치는 약 416,514달러이며, 회사의 총 발행 주식 9,070만 주의 약 0.05%에 해당합니다. 제안된 매도는 NYSE의 Merrill Lynch를 통해 실행될 예정입니다.
제출서에는 지난 3개월 동안 내부자의 광범위한 거래 내역도 공개되어 있습니다: Kauffman/Aldel은 2025년 4월 24일부터 7월 9일까지 약 542,700주를 매도하여 약 535만 달러의 총 수익을 올렸습니다. 이 매도는 총 발행 주식의 약 0.6%에 불과하지만, 2021년 사업 결합 PIPE에서 Aldel이 350만 주를 인수한 이후 보유 지분을 지속적이고 체계적으로 축소하고 있음을 시사할 수 있습니다.
Form 144는 운영 실적이나 수익 데이터가 포함되어 있지 않으며, 단순히 계획된 매도 사실을 공시하는 문서입니다. 투자자들은 내부자의 심리와 잠재적 매도 물량을 파악하기 위해 이러한 제출서를 주로 관찰합니다. Hagerty의 유통 주식 수에 비해 규모가 작아 즉각적인 주가 영향은 제한적일 것으로 예상되나, 누적된 매도 추세가 지속될 경우 투자 심리에 부담을 줄 수 있습니다.
Hagerty, Inc. (HGTY) — Dépôt du formulaire 144 en date du 10 juillet 2025
Robert I. Kauffman, agissant par l’intermédiaire d’Aldel LLC, a déposé un formulaire 144 annonçant son intention de vendre 41 239 actions ordinaires de Hagerty, Inc. aux alentours du 10/07/2025. Au prix de clôture du 09/07/2025 indiqué dans le dépôt, la transaction est estimée à 416 514 $ et représente environ 0,05 % des 90,7 millions d’actions en circulation de la société. La vente proposée sera réalisée via Merrill Lynch à la NYSE.
Le dépôt révèle également une activité importante d’initiés au cours des trois mois précédents : Kauffman/Aldel ont vendu environ 542 700 actions pour un produit brut d’environ 5,35 millions de $ entre le 24 avril et le 09 juillet 2025. Bien que ces cessions ne représentent qu’environ 0,6 % des actions en circulation, elles pourraient indiquer une réduction continue et méthodique de la position du déposant suite à la PIPE de fusion d’entreprise en 2021, au cours de laquelle Aldel a acquis 3,5 millions d’actions.
Le formulaire 144 ne comprend pas de données opérationnelles ou de résultats, étant strictement une déclaration de vente prévue. Les investisseurs surveillent généralement ces dépôts pour évaluer le sentiment des initiés et la pression potentielle sur l’offre. Étant donné la taille modeste par rapport au flottant de Hagerty, l’impact immédiat sur le cours devrait être limité ; néanmoins, la tendance cumulative à la vente pourrait peser sur le sentiment si elle se poursuit.
Hagerty, Inc. (HGTY) — Form 144 Einreichung vom 10. Juli 2025
Robert I. Kauffman, handelnd über Aldel LLC, reichte ein Form 144 ein, um den beabsichtigten Verkauf von 41.239 Stammaktien von Hagerty, Inc. etwa am 10.07.2025 zu melden. Zum Schlusskurs vom 09.07.2025, der in der Einreichung angegeben ist, beläuft sich der Wert der Transaktion auf 416.514 $ und entspricht etwa 0,05% der 90,7 Millionen ausstehenden Aktien des Unternehmens. Der geplante Verkauf wird über Merrill Lynch an der NYSE abgewickelt.
Die Einreichung offenbart zudem umfangreiche Insideraktivitäten im vorangegangenen Dreimonatszeitraum: Kauffman/Aldel verkaufte zwischen dem 24. April und dem 09. Juli 2025 etwa 542.700 Aktien und erzielte daraus Bruttoerlöse von rund 5,35 Millionen $. Obwohl diese Verkäufe nur etwa 0,6% der ausstehenden Aktien entsprechen, könnten sie auf eine fortgesetzte, methodische Reduzierung der Position des Meldenden nach der PIPE-Beteiligung an der Unternehmensfusion 2021 hindeuten, bei der Aldel 3,5 Millionen Aktien erwarb.
Das Form 144 enthält keine operativen oder Ergebnisdaten, da es sich ausschließlich um eine Offenlegung eines geplanten Verkaufs handelt. Investoren beobachten solche Meldungen typischerweise, um die Insider-Stimmung und potenzielle Angebotsüberhänge einzuschätzen. Angesichts der vergleichsweise geringen Größe im Verhältnis zum Streubesitz von Hagerty wird ein unmittelbarer Kurseinfluss als begrenzt erwartet; dennoch könnte der kumulative Verkaufstrend die Stimmung belasten, falls er anhält.
- Sale size is immaterial – 41,239 shares represent only 0.05 % of outstanding stock, limiting immediate market impact.
- Regulatory compliance – Detailed Form 144 demonstrates transparent adherence to SEC rules, reducing governance concerns.
- Continued insider selling – ≈542.7k shares (0.6 % of float) sold over the last three months may signal waning insider confidence.
- Potential sentiment overhang – Persistent PIPE holder sales could pressure valuation despite small relative size.
Insights
TL;DR – Modest insider sale adds to a three-month trend but is immaterial to float; sentiment mildly negative.
The 41.2k-share notice is routine on an absolute basis, yet comes on the heels of ≈542.7k shares already sold in Q2-Q3 2025. At $5.4 million cumulative proceeds, Kauffman has trimmed about 15 % of his original 3.5 million PIPE stake. The percentage of float remains de minimis, so supply-demand dynamics should absorb the shares easily. However, recurring sales by a PIPE sponsor can pressure sentiment among growth-oriented investors who look for insider alignment. No new information about Hagerty’s fundamentals is provided, so the filing is not impactful to intrinsic value, but it is a noteworthy data point for those tracking insider behavior.
TL;DR – Continued dispositions show orderly compliance; governance risk unchanged.
Kauffman’s adherence to Rule 144 timing, broker disclosure, and aggregation reporting indicates proper governance practice. The staggered, open-market strategy suggests the seller is minimizing disruption rather than executing a block trade, reducing potential volatility. There is no indication of undisclosed adverse information, as the signatory attests. From a governance perspective, the activity appears routine, and the company’s disclosure controls remain intact.
Hagerty, Inc. (HGTY) — Deposito del Modulo 144 datato 10 luglio 2025
Robert I. Kauffman, tramite Aldel LLC, ha presentato un Modulo 144 notificando l’intenzione di vendere 41.239 azioni ordinarie di Hagerty, Inc. intorno al 10/07/2025. Al prezzo di chiusura del 09/07/2025 indicato nel deposito, la transazione ha un valore di circa 416.514 $ e rappresenta circa lo 0,05% delle 90,7 milioni di azioni in circolazione della società. La vendita sarà effettuata tramite Merrill Lynch alla NYSE.
Il deposito rivela inoltre un’intensa attività interna negli ultimi tre mesi: Kauffman/Aldel ha venduto circa 542.700 azioni per un ricavo lordo di circa 5,35 milioni di $ tra il 24 aprile e il 09 luglio 2025. Sebbene queste vendite rappresentino solo circa lo 0,6% delle azioni in circolazione, potrebbero indicare una riduzione continua e metodica della posizione del depositante dopo la PIPE di combinazione aziendale del 2021, in cui Aldel ha acquisito 3,5 milioni di azioni.
Il Modulo 144 non include dati operativi o sugli utili, essendo esclusivamente una comunicazione di vendita pianificata. Gli investitori monitorano questi depositi per valutare il sentiment interno e l’eventuale pressione di offerta. Considerata la dimensione modesta rispetto al flottante di Hagerty, l’impatto immediato sul prezzo dovrebbe essere limitato; tuttavia, la tendenza cumulativa alla vendita potrebbe influenzare il sentiment se dovesse continuare.
Hagerty, Inc. (HGTY) — Presentación del Formulario 144 con fecha 10 de julio de 2025
Robert I. Kauffman, actuando a través de Aldel LLC, presentó un Formulario 144 notificando su intención de vender 41.239 acciones ordinarias de Hagerty, Inc. alrededor del 10/07/2025. Al precio de cierre del 09/07/2025 indicado en la presentación, la transacción tiene un valor aproximado de 416.514 $ y representa aproximadamente el 0,05% de las 90,7 millones de acciones en circulación de la compañía. La venta se realizará a través de Merrill Lynch en la NYSE.
La presentación también revela una actividad interna intensa durante los últimos tres meses: Kauffman/Aldel vendió aproximadamente 542.700 acciones por unos ingresos brutos de 5,35 millones de $ entre el 24 de abril y el 09 de julio de 2025. Aunque estas disposiciones representan solo cerca del 0,6% de las acciones en circulación, podrían indicar una reducción continua y metódica de la posición del declarante tras la PIPE de combinación empresarial de 2021, en la que Aldel adquirió 3,5 millones de acciones.
El Formulario 144 no incluye datos operativos ni de ganancias, ya que es únicamente una divulgación de una venta planificada. Los inversores suelen monitorear estas presentaciones para evaluar el sentimiento interno y la posible presión de oferta. Dada la modesta dimensión en relación con el flotante de Hagerty, se espera que el impacto inmediato en el precio sea limitado; sin embargo, la tendencia acumulativa de ventas podría afectar el sentimiento si persiste.
Hagerty, Inc. (HGTY) — 2025년 7월 10일자 Form 144 제출
Robert I. Kauffman이 Aldel LLC를 통해 약 2025년 7월 10일경에 Hagerty, Inc.의 41,239 보통주를 매도할 의사를 알리는 Form 144를 제출했습니다. 제출서에 명시된 2025년 7월 9일 종가 기준으로 이 거래의 가치는 약 416,514달러이며, 회사의 총 발행 주식 9,070만 주의 약 0.05%에 해당합니다. 제안된 매도는 NYSE의 Merrill Lynch를 통해 실행될 예정입니다.
제출서에는 지난 3개월 동안 내부자의 광범위한 거래 내역도 공개되어 있습니다: Kauffman/Aldel은 2025년 4월 24일부터 7월 9일까지 약 542,700주를 매도하여 약 535만 달러의 총 수익을 올렸습니다. 이 매도는 총 발행 주식의 약 0.6%에 불과하지만, 2021년 사업 결합 PIPE에서 Aldel이 350만 주를 인수한 이후 보유 지분을 지속적이고 체계적으로 축소하고 있음을 시사할 수 있습니다.
Form 144는 운영 실적이나 수익 데이터가 포함되어 있지 않으며, 단순히 계획된 매도 사실을 공시하는 문서입니다. 투자자들은 내부자의 심리와 잠재적 매도 물량을 파악하기 위해 이러한 제출서를 주로 관찰합니다. Hagerty의 유통 주식 수에 비해 규모가 작아 즉각적인 주가 영향은 제한적일 것으로 예상되나, 누적된 매도 추세가 지속될 경우 투자 심리에 부담을 줄 수 있습니다.
Hagerty, Inc. (HGTY) — Dépôt du formulaire 144 en date du 10 juillet 2025
Robert I. Kauffman, agissant par l’intermédiaire d’Aldel LLC, a déposé un formulaire 144 annonçant son intention de vendre 41 239 actions ordinaires de Hagerty, Inc. aux alentours du 10/07/2025. Au prix de clôture du 09/07/2025 indiqué dans le dépôt, la transaction est estimée à 416 514 $ et représente environ 0,05 % des 90,7 millions d’actions en circulation de la société. La vente proposée sera réalisée via Merrill Lynch à la NYSE.
Le dépôt révèle également une activité importante d’initiés au cours des trois mois précédents : Kauffman/Aldel ont vendu environ 542 700 actions pour un produit brut d’environ 5,35 millions de $ entre le 24 avril et le 09 juillet 2025. Bien que ces cessions ne représentent qu’environ 0,6 % des actions en circulation, elles pourraient indiquer une réduction continue et méthodique de la position du déposant suite à la PIPE de fusion d’entreprise en 2021, au cours de laquelle Aldel a acquis 3,5 millions d’actions.
Le formulaire 144 ne comprend pas de données opérationnelles ou de résultats, étant strictement une déclaration de vente prévue. Les investisseurs surveillent généralement ces dépôts pour évaluer le sentiment des initiés et la pression potentielle sur l’offre. Étant donné la taille modeste par rapport au flottant de Hagerty, l’impact immédiat sur le cours devrait être limité ; néanmoins, la tendance cumulative à la vente pourrait peser sur le sentiment si elle se poursuit.
Hagerty, Inc. (HGTY) — Form 144 Einreichung vom 10. Juli 2025
Robert I. Kauffman, handelnd über Aldel LLC, reichte ein Form 144 ein, um den beabsichtigten Verkauf von 41.239 Stammaktien von Hagerty, Inc. etwa am 10.07.2025 zu melden. Zum Schlusskurs vom 09.07.2025, der in der Einreichung angegeben ist, beläuft sich der Wert der Transaktion auf 416.514 $ und entspricht etwa 0,05% der 90,7 Millionen ausstehenden Aktien des Unternehmens. Der geplante Verkauf wird über Merrill Lynch an der NYSE abgewickelt.
Die Einreichung offenbart zudem umfangreiche Insideraktivitäten im vorangegangenen Dreimonatszeitraum: Kauffman/Aldel verkaufte zwischen dem 24. April und dem 09. Juli 2025 etwa 542.700 Aktien und erzielte daraus Bruttoerlöse von rund 5,35 Millionen $. Obwohl diese Verkäufe nur etwa 0,6% der ausstehenden Aktien entsprechen, könnten sie auf eine fortgesetzte, methodische Reduzierung der Position des Meldenden nach der PIPE-Beteiligung an der Unternehmensfusion 2021 hindeuten, bei der Aldel 3,5 Millionen Aktien erwarb.
Das Form 144 enthält keine operativen oder Ergebnisdaten, da es sich ausschließlich um eine Offenlegung eines geplanten Verkaufs handelt. Investoren beobachten solche Meldungen typischerweise, um die Insider-Stimmung und potenzielle Angebotsüberhänge einzuschätzen. Angesichts der vergleichsweise geringen Größe im Verhältnis zum Streubesitz von Hagerty wird ein unmittelbarer Kurseinfluss als begrenzt erwartet; dennoch könnte der kumulative Verkaufstrend die Stimmung belasten, falls er anhält.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
UNDER
THE SECURITIES ACT OF 1933
|
Switzerland
(State or other jurisdiction of incorporation or organization)
|
| |
98-1743397
(I.R.S. Employer Identification Number)
|
|
|
Delaware
(State or other jurisdiction of incorporation or organization)
|
| |
26-002-1554
(I.R.S. Employer Identification Number)
|
|
1206 Geneva, Switzerland
+41 22 592 91 00
(Address, including zip code, and telephone number, including area code, of registrant’s registered office and principal executive offices)
Chesterfield, Missouri, 63017
(314) 292-2000
(Address, including zip code, and telephone number, including area code, of registrant’s corporate headquarters)
1391 Timberlake Manor Parkway
Chesterfield, Missouri, 63017
Attention: Lisa Ware-Alexander
Vice President, Deputy General Counsel, Corporate Secretary, Chief Compliance & Ethics Officer
(314) 292-2000
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Krunal P. Shah
Jones Day
1221 Peachtree St. NE Ste 400
Atlanta, GA 30361
Phone: (404) 521-3939
Fax: (404) 581-8330
|
Large accelerated filer
☒
|
| |
Accelerated filer
☐
|
|
|
Non-accelerated filer
☐
|
| |
Smaller reporting company
☐
|
|
| | | |
Emerging growth company
☐
|
|
![[MISSING IMAGE: lg_bunge-4c.jpg]](https://www.sec.gov/Archives/edgar/data/0001996862/000110465925066996/lg_bunge-4c.jpg)
for Newly Issued and Registered 2.000% Senior Notes Due 2026
for Newly Issued and Registered 4.900% Senior Notes Due 2027
for Newly Issued and Registered 3.200% Senior Notes Due 2031
for Newly Issued and Registered 5.250% Senior Notes Due 2032
|
WHERE YOU CAN FIND ADDITIONAL INFORMATION
|
| | | | ii | | |
|
INFORMATION WE INCORPORATE BY REFERENCE
|
| | | | ii | | |
|
SUMMARY
|
| | | | 1 | | |
|
RISK FACTORS
|
| | | | 14 | | |
|
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
|
| | | | 17 | | |
|
USE OF PROCEEDS
|
| | | | 18 | | |
|
THE EXCHANGE OFFERS
|
| | | | 19 | | |
|
DESCRIPTION OF THE NOTES
|
| | | | 26 | | |
|
CERTAIN U.S. FEDERAL INCOME TAX CONSIDERATIONS
|
| | | | 44 | | |
|
CERTAIN ERISA CONSIDERATIONS
|
| | | | 45 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 47 | | |
|
LEGAL MATTERS
|
| | | | 48 | | |
|
EXPERTS
|
| | | | 48 | | |
1391 Timberlake Manor Parkway
Chesterfield, MO 63017
Telephone Number: (314) 292-2000
Attn: Secretary
| The Exchange Offers | | | BLFC is offering to exchange up to (i) $579,763,000 aggregate principal amount of its registered 2.000% Senior Notes due 2026 for an equal principal amount of our outstanding Original 2026 Notes, (ii) $439,733,000 aggregate principal amount of its registered 4.900% Senior Notes due 2027 for an equal principal amount of its outstanding Original 2027 Notes, (iii) $598,591,000 aggregate principal amount of its registered 3.200% Senior Notes due 2031 for an equal principal amount of its outstanding Original 2031 Notes, and (iv) $299,800,000 aggregate principal amount of its registered 5.250% Senior Notes due 2032 for an equal principal amount of our outstanding Original 2032 Notes. The terms of each series of Exchange Notes are identical in all material respects to those of the corresponding series of Original Notes, except for transfer restrictions and registration rights and related additional interest provisions relating to the Original Notes. Each series of Exchange Notes will be part of the same series as the corresponding series of Original Notes and will be issued under the same Indenture. Holders of Original Notes do not have any appraisal or dissenters’ rights in connection with the Exchange Offers. | |
|
Purpose of the Exchange
Offers |
| | The Exchange Notes are being offered to satisfy BLFC’s obligations under the registration rights agreement entered into at the time it issued and sold the Original Notes. | |
| Expiration Date; Withdrawal of Tenders; Return of Original Notes Not Accepted for Exchange | | | The Exchange Offers will expire at 5:00 p.m., New York City time, on , 2025 or on a later date and time to which BLFC extends it. This prospectus refers to such time and date as the Expiration Date. Tenders of Original Notes in the Exchange Offers may be withdrawn at any time prior to the Expiration Date. BLFC will exchange the Exchange Notes for validly tendered Original Notes promptly following the Expiration Date. This prospectus refers to such date of exchange as the “Exchange Date.” Any Original Notes that are not accepted for exchange for any reason will be returned by BLFC, at its expense, to the tendering holder promptly after the expiration or termination of the Exchange Offers. | |
| Procedures for Tendering Original Notes | | |
Each holder of Original Notes wishing to participate in the Exchange Offers must follow procedures of The Depository Trust Company’s, or DTC, Automated Tender Offer Program, or “ATOP,” subject to the terms and procedures of that program. The ATOP procedures require that the exchange agent receives, prior to the Expiration Date, a computer-generated message known as an “agent’s message” that is transmitted through ATOP and that DTC confirms that:
•
DTC has received instructions to exchange your Original Notes; and
•
you agree to be bound by the terms of the letter of
|
|
| | | |
transmittal.See “The Exchange Offers — Procedures for Tendering Original Notes.”
|
|
| Consequences of Failure to Exchange Original Notes | | | You will continue to hold Original Notes, which will remain subject to their existing transfer restrictions, if you do not validly tender your Original Notes or you tender your Original Notes and they are not accepted for exchange. With some limited exceptions, BLFC will have no obligation to register the Original Notes after it consummates the Exchange Offers. See “The Exchange Offers — Terms of the Exchange Offers” and “The Exchange Offers — Consequences of Failure to Exchange.” | |
| Conditions to the Exchange Offers | | | The Exchange Offers are not conditioned upon any minimum aggregate principal amount of Original Notes of the applicable series being tendered or accepted for exchange. The Exchange Offers are subject to customary conditions, which may be waived by BLFC in its discretion. BLFC currently expects that all of the conditions will be satisfied and that no waivers will be necessary. See “The Exchange Offers — Conditions to the Exchange Offers.” | |
| Exchange Agent | | | D.F. King & Co., Inc. (“D.F. King”). | |
| Certain U.S. Federal Income Tax Considerations | | | As described in “Certain U.S. Federal Income Tax Considerations,” the exchange of an Original Note for an Exchange Note of the corresponding series pursuant to the Exchange Offers will not constitute a taxable exchange and will not result in any taxable income, gain or loss for U.S. federal income tax purposes, and immediately after the exchange, a holder will have the same adjusted tax basis and holding period in each Exchange Note received as such holder had immediately prior to the exchange in the corresponding Original Note surrendered. | |
| Risk Factors | | | You should carefully read and consider the risk factors beginning on page 14 of this prospectus before deciding whether to participate in the Exchange Offers. | |
| Issuer | | | Bunge Limited Finance Corp., a Delaware corporation. | |
| Guarantor | | | Bunge Global SA, a Swiss corporation. | |
| Securities Offered | | | Up to $1,917,887,000 aggregate principal amount of Exchange Notes, consisting of up to $579,763,000 aggregate principal amount of 2.000% Senior Notes due 2026; up to $439,733,000 aggregate principal amount of 4.900% Senior Notes due 2027; up to $598,591,000 aggregate principal amount of 3.200% Senior Notes due 2031; and up to $299,800,000 aggregate principal amount of 5.250% Senior Notes due 2032. | |
| Maturity Dates | | | The New 2026 Notes will mature on April 21, 2026; the New 2027 Notes will mature on April 21, 2027; the New 2031 Notes will mature on April 21, 2031; and the New 2032 Notes will mature on April 21, 2032. | |
| Interest Rates | | | The New 2026 Notes will bear interest at 2.000% per year; the New 2027 Notes will bear interest at 4.900% per year; the New 2031 Notes will bear interest at 3.200% per year; and the New 2032 Notes will bear interest at 5.250% per year. | |
| Accrual of Interest | | | Each series of Exchange Notes will accrue interest from (and including) the most recent date on which interest has been paid on the corresponding series of Original Notes accepted in the Exchange Offers or, if no interest has been paid, from April 21, 2025. | |
| Interest Payment Dates | | | BLFC will pay interest on the Exchange Notes on April 21 and October 21 of each year, commencing on October 21, 2025. In each case, if the record date for the first interest payment date occurs on or prior to the Exchange Date, the record date for the first interest payment date will be deemed the close of business on the business day immediately prior to such interest payment date. | |
| Optional Redemption | | | BLFC may redeem the Notes of each series, in whole or in part, at any time and from time to time at the applicable redemption price described herein under the caption “Description of the Notes — Optional Redemption.” | |
| Offer to Repurchase Upon Change of Control Triggering Event | | | Upon the occurrence of a “Change of Control Triggering Event,” as defined under the caption “Description of the Notes — Purchase of Notes Upon a Change of Control Triggering Event” with respect to a series of Notes, BLFC will be required to make an offer to repurchase the Notes of such series in cash at a price equal to 101% of their principal amount, plus accrued and unpaid interest to, but not including, the date of repurchase. | |
| Certain Covenants | | |
The Indentures governing the Exchange Notes contain covenants that will restrict BLFC’s ability, with certain exceptions, to:
•
incur debt secured by liens;
•
engage in sale and leaseback transactions; and
|
|
| | | |
•
enter into certain consolidations, mergers and transfers of all or substantially all of the assets of BLFC and its subsidiaries, taken as a whole.
|
|
| | | | See “Description of the Notes — Certain Covenants.” | |
| Ranking | | | The Exchange Notes will be BLFC’s senior unsecured obligations and will rank equally with all of BLFC’s other existing and future senior unsecured obligations, including all other unsubordinated debt securities that may be issued pursuant to the Indentures and from time to time outstanding. The Indentures do not restrict the issuance by BLFC of senior unsecured debt. See “Description of the Notes — Ranking.” | |
| Guarantee | | | All payments on the Exchange Notes, including principal and interest, will be fully, unconditionally and irrevocably guaranteed by Bunge. Bunge’s guarantee will rank equally in right of payment with its other unsecured and unsubordinated indebtedness and guarantees. | |
| Form and Denomination | | | The Exchange Notes of each series will be issued in denominations of $2,000 and in integral multiples of $1,000 in excess thereof. | |
| DTC Eligibility | | | The Exchange Notes of each series will be represented by global certificates deposited with, or on behalf of, DTC or its nominee. See “Description of the Notes — Book-Entry; Delivery and Form.” | |
| Same Day Settlement | | | Beneficial interests in the Exchange Notes will trade in DTC’s same-day funds settlement system until maturity. Therefore, secondary market trading activity in such interests will be settled in immediately available funds. | |
| No Listing of the Exchange Notes | | | BLFC does not intend to apply to list the Exchange Notes on any securities exchange or to have the Exchange Notes quoted on any automated quotation system. | |
| Governing Law | | | The Exchange Notes and the related Indentures will be governed by the laws of the State of New York. | |
| Use of Proceeds | | | BLFC will not receive any cash proceeds from the issuance of the Exchange Notes. See “Use of Proceeds.” | |
| Trustee, Registrar and Paying Agent | | | U.S. Bank Trust Company, National Association. | |
| Risk Factors | | | See “Risk Factors” and other information in this prospectus for a discussion of factors that should be carefully considered by the holders of Original Notes before tendering their Original Notes in the Exchange Offers and investing in the Exchange Notes. | |
| | |
Three Months Ended March 31,
|
| |
Year Ended December 31,
|
| ||||||||||||||||||||||||
| | |
2025
|
| |
2024
|
| |
2024
|
| |
2023
|
| |
2022
|
| |||||||||||||||
| | |
(U.S. dollars in millions, except share data)
|
| |||||||||||||||||||||||||||
Consolidated Statements of Income Data | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net sales
|
| | | $ | 11,643 | | | | | $ | 13,417 | | | | | $ | 53,108 | | | | | $ | 59,540 | | | | | $ | 67,232 | | |
Cost of goods sold
|
| | | | (11,046) | | | | | | (12,541) | | | | | | (49,715) | | | | | | (54,695) | | | | | | (63,550) | | |
Gross profit
|
| | | | 597 | | | | | | 876 | | | | | | 3,393 | | | | | | 4,845 | | | | | | 3,682 | | |
Selling, general and administrative expenses
|
| | | | (380) | | | | | | (439) | | | | | | (1,776) | | | | | | (1,715) | | | | | | (1,369) | | |
Interest income
|
| | | | 59 | | | | | | 42 | | | | | | 163 | | | | | | 148 | | | | | | 71 | | |
Interest expense
|
| | | | (104) | | | | | | (108) | | | | | | (471) | | | | | | (516) | | | | | | (403) | | |
Foreign exchange gains (losses) – net
|
| | | | 25 | | | | | | (78) | | | | | | (189) | | | | | | 20 | | | | | | (11) | | |
Other income (expense) – net
|
| | | | 82 | | | | | | 68 | | | | | | 442 | | | | | | 129 | | | | | | (9) | | |
Income (loss) from affiliates
|
| | | | 5 | | | | | | 8 | | | | | | (38) | | | | | | 140 | | | | | | 105 | | |
Income before income tax
|
| | | | 284 | | | | | | 369 | | | | | | 1,524 | | | | | | 3,051 | | | | | | 2,066 | | |
Income tax expense
|
| | | | (80) | | | | | | (117) | | | | | | (336) | | | | | | (714) | | | | | | (388) | | |
Net income
|
| | | | 204 | | | | | | 252 | | | | | | 1,188 | | | | | | 2,337 | | | | | | 1,678 | | |
Net (income) attributable to noncontrolling interests and redeemable noncontrolling interests
|
| | | | (3) | | | | | | (8) | | | | | | (51) | | | | | | (94) | | | | | | (68) | | |
Net income attributable to Bunge shareholders
|
| | | $ | 201 | | | | | $ | 244 | | | | | $ | 1,137 | | | | | $ | 2,243 | | | | | $ | 1,610 | | |
| | |
Three Months Ended March 31,
|
| |
Year Ended December 31,
|
| ||||||||||||||||||||||||
| | |
2025
|
| |
2024
|
| |
2024
|
| |
2023
|
| |
2022
|
| |||||||||||||||
| | |
(U.S. dollars in millions, except share data)
|
| |||||||||||||||||||||||||||
Earnings per share – basic(1) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net income attributable to Bunge shareholders – basic
|
| | | $ | 1.50 | | | | | $ | 1.70 | | | | | $ | 8.09 | | | | | $ | 15.07 | | | | | $ | 10.83 | | |
Earnings per share – diluted(2) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net income attributable to Bunge shareholders – diluted
|
| | | $ | 1.48 | | | | | $ | 1.68 | | | | | $ | 7.99 | | | | | $ | 14.87 | | | | | $ | 10.51 | | |
Cash dividends paid per share
|
| | | $ | 0.68 | | | | | $ | 0.6625 | | | | | $ | 2.7025 | | | | | $ | 2.575 | | | | | $ | 2.30 | | |
Weighted average shares outstanding – basic
|
| | | | 134,061,601 | | | | | | 143,501,016 | | | | | | 140,539,652 | | | | | | 148,804,387 | | | | | | 148,712,251 | | |
Weighted average shares outstanding – diluted
|
| | | | 135,407,823 | | | | | | 145,414,139 | | | | | | 142,223,221 | | | | | | 150,787,917 | | | | | | 153,134,754 | | |
| | |
As of March 31,
|
| |
As of December 31,
|
| ||||||||||||||||||
| | |
2025
|
| |
2024
|
| |
2024
|
| |
2023
|
| ||||||||||||
| | |
(U.S. dollars in millions)
|
| |||||||||||||||||||||
Consolidated Balance Sheet Data | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 3,245 | | | | | $ | 2,939 | | | | | $ | 3,311 | | | | | $ | 2,602 | | |
Inventories(3) | | | | | 7,817 | | | | | | 7,505 | | | | | | 6,491 | | | | | | 7,105 | | |
Working capital(4)
|
| | | | 8,838 | | | | | | 8,311 | | | | | | 8,523 | | | | | | 8,663 | | |
Total assets
|
| | | | 26,660 | | | | | | 25,821 | | | | | | 24,899 | | | | | | 25,372 | | |
Short-term debt, including Current portion of long-term debt
|
| | | | 2,003 | | | | | | 1,016 | | | | | | 1,544 | | | | | | 802 | | |
Long-term debt
|
| | | | 4,714 | | | | | | 4,079 | | | | | | 4,694 | | | | | | 4,080 | | |
Registered shares and Additional paid-in-capital
|
| | | | 5,491 | | | | | | 5,855 | | | | | | 5,326 | | | | | | 5,901 | | |
Total equity
|
| | | | 11,544 | | | | | | 11,528 | | | | | | 10,945 | | | | | | 11,814 | | |
Total liabilities, redeemable noncontrolling interest and equity
|
| | | | 26,660 | | | | | | 25,821 | | | | | | 24,899 | | | | | | 25,372 | | |
| | |
Three Months Ended
March 31, |
| |
Year Ended December 31,
|
| ||||||||||||||||||
| | |
2025
|
| |
2024
|
| |
2024
|
| |
2023
|
| ||||||||||||
| | |
(U.S. dollars in millions)
|
| |||||||||||||||||||||
Consolidated Statement of Income | | | | | | | | | | | | | | | | | | | | | | | | | |
Revenue
|
| | | $ | 10,038 | | | | | $ | 11,458 | | | | | $ | 44,226 | | | | | $ | 54,673 | | |
Cost of goods sold
|
| | | | (9,883) | | | | | | (11,184) | | | | | | (42,923) | | | | | | (52,971) | | |
Gross margin
|
| | | | 155 | | | | | | 274 | | | | | | 1,303 | | | | | | 1,702 | | |
Selling and administrative expenses
|
| | | | (158) | | | | | | (151) | | | | | | (707) | | | | | | (467) | | |
Share of income from associates and joint ventures
|
| | | | 1 | | | | | | 11 | | | | | | 43 | | | | | | 52 | | |
Gain on disposals of investments
|
| | | | — | | | | | | 1 | | | | | | 1 | | | | | | 31 | | |
Loss of remeasurement of disposal group held for sale
|
| | | | — | | | | | | — | | | | | | — | | | | | | (162) | | |
Impairment (expense)/release on trade receivables
|
| | | | (3) | | | | | | (3) | | | | | | (2) | | | | | | 6 | | |
Other income
|
| | | | 2 | | | | | | 1 | | | | | | 7 | | | | | | 124 | | |
Other expense
|
| | | | (8) | | | | | | (4) | | | | | | (6) | | | | | | (99) | | |
Dividend income
|
| | | | — | | | | | | 1 | | | | | | 2 | | | | | | 3 | | |
Interest income
|
| | | | 8 | | | | | | 10 | | | | | | 44 | | | | | | 47 | | |
Interest expense
|
| | | | (115) | | | | | | (139) | | | | | | (479) | | | | | | (573) | | |
Income before income taxes
|
| | | | (118) | | | | | | 1 | | | | | | 206 | | | | | | 664 | | |
Current income tax expense
|
| | | | (37) | | | | | | (44) | | | | | | (163) | | | | | | (305) | | |
Deferred income tax recovery
|
| | | | 26 | | | | | | 107 | | | | | | 65 | | | | | | 94 | | |
Income for the period
|
| | | $ | (129) | | | | | $ | 64 | | | | | $ | 108 | | | | | $ | 453 | | |
Attributable to: | | | | | | | | | | | | | | | | | | | | | | | | | |
Non-controlling interests
|
| | | | — | | | | | | — | | | | | | (1) | | | | | | 7 | | |
Equity holders
|
| | | | (129) | | | | | | 64 | | | | | | 109 | | | | | | 446 | | |
| | |
As of March 31,
|
| |
As of December 31,
|
| ||||||||||||
| | |
2025
|
| |
2024
|
| |
2023
|
| |||||||||
| | |
(U.S. dollars in millions)
|
| |||||||||||||||
Consolidated Statement of Financial Position | | | | | | | | | | | | | | | | | | | |
Non-current assets
|
| | | $ | 6,550 | | | | | $ | 6,564 | | | | | $ | 7,265 | | |
Inventories(1) | | | | | 6,933 | | | | | | 7,045 | | | | | | 7,117 | | |
Cash and cash equivalents(2)
|
| | | | 729 | | | | | | 688 | | | | | | 530 | | |
Current assets
|
| | | | 11,837 | | | | | | 12,279 | | | | | | 12,224 | | |
Working capital(3)
|
| | | | 4,340 | | | | | | 3,547 | | | | | | 4,357 | | |
Total assets
|
| | | | 18,387 | | | | | $ | 18,843 | | | | | $ | 19,489 | | |
Share capital, reserves and retained earnings
|
| | | | 4,658 | | | | | | 4,783 | | | | | | 5,181 | | |
Non-controlling interests
|
| | | | 158 | | | | | | 158 | | | | | | 163 | | |
Total equity
|
| | | | 4,816 | | | | | | 4,941 | | | | | | 5,344 | | |
Non-current borrowings
|
| | | | 5,441 | | | | | | 4,469 | | | | | | 5,480 | | |
Current borrowings
|
| | | | 3,363 | | | | | | 3,653 | | | | | | 2,430 | | |
Total equity and liabilities
|
| | | | 18,387 | | | | | $ | 18,843 | | | | | $ | 19,489 | | |
(U.S. dollars in millions, except per share data)
| | |
Pro Forma Combined
Three Months Ended March 31, 2025 |
| |
Pro Forma Combined
Year Ended December 31, 2024 |
| ||||||
Net sales
|
| | | $ | 20,903 | | | | | $ | 93,931 | | |
Income before income taxes
|
| | | | 151 | | | | | | 1,627 | | |
Net income
|
| | | | 66 | | | | | | 1,218 | | |
Net income per share: | | | | | | | | | | | | | |
Basic
|
| | | $ | 0.31 | | | | | $ | 5.67 | | |
Diluted
|
| | | $ | 0.31 | | | | | $ | 5.62 | | |
(U.S. dollars in millions)
| | |
Pro Forma Combined
March 31, 2025 |
| |||
Total current assets
|
| | | $ | 26,946 | | |
Goodwill
|
| | | | 2,547 | | |
Other intangible assets, net
|
| | | | 364 | | |
Property, plant and equipment, net
|
| | | | 11,242 | | |
Total assets
|
| | | $ | 45,732 | | |
Long-term debt
|
| | | | 11,462 | | |
Total Bunge shareholders’ equity
|
| | | | 15,815 | | |
Total liabilities, redeemable noncontrolling interest and equity
|
| | | $ | 45,732 | | |
or Certified Mail Recommended):
Attn: Michael Horthman
48 Wall Street, 22nd Floor
New York, NY 10005
(212) 652-2403
(800) 967-5074
![[MISSING IMAGE: lg_bunge-4c.jpg]](https://www.sec.gov/Archives/edgar/data/0001996862/000110465925066996/lg_bunge-4c.jpg)
for Newly Issued and Registered 2.000% Senior Notes Due 2026
for Newly Issued and Registered 4.900% Senior Notes Due 2027
for Newly Issued and Registered 3.200% Senior Notes Due 2031
for Newly Issued and Registered 5.250% Senior Notes Due 2032
Exhibit
No. |
| |
Description of Exhibit
|
| |||
| | 3.1 | | | |
Articles of Association of Bunge Global SA, filed as Exhibit 3.1 to the Company’s Form 8-K dated
December 9, 2024, and incorporated herein by reference. |
|
| | 3.2 | | | | Organizational Regulations of Bunge Global SA, filed as Exhibit 3.2 to the Company’s Form 8-K12G3 dated November 1, 2023, and incorporated herein by reference. | |
| | 3.3 | | | | Certificate of Incorporation of Bunge Limited Finance Corp., filed as Exhibit 3.3 to the Company’s Registration Statement on Form F-4 (No. 333-104975-01) filed May 5, 2003, and incorporated herein by reference. | |
| | 3.4 | | | | By-laws of Bunge Limited Finance Corp., filed as Exhibit 3.4 to the Company’s Registration Statement on Form F-4 (No. 333-104975-01) filed May 5, 2003, and incorporated herein by reference. | |
| | 4.1 | | | | Indenture by and among Bunge Limited Finance Corp., the Company and U.S. Bank Trust Company, National Association, dated September 17, 2024, filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated September 17, 2024, and incorporated herein by reference. | |
| | 4.2 | | | |
Second Supplemental Indenture by and among Bunge Limited Finance Corp., the Company and
U.S. Bank Trust Company, National Association, dated July 8, 2025, filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated July 8, 2025, and incorporated herein by reference. |
|
| | 4.3 | | | | Registration Rights Agreement, dated July 8, 2025, by and among Bunge Limited Finance Corp., as issuer, and each of BofA Securities, Inc., JPMorgan Chase & Co., and SMBC Nikko Securities America, Inc. as dealer managers, filed as Exhibit 4.6 to the Company’s Current Report on Form 8-K dated July 8, 2025, and incorporated herein by reference. | |
| | 5.1 | | | | Opinion of Jones Day. | |
| | 5.2 | | | | Opinion of Homburger AG. | |
| | 23.1 | | | | Consent of Deloitte & Touche LLP, as the independent registered public accounting firm for Bunge Global SA. | |
| | 23.2 | | | | Consent of Deloitte LLP, independent auditor of Viterra Limited. | |
| | 23.3 | | | | Consent of Jones Day (Included in Exhibit 5.1). | |
| | 23.4 | | | | Consent of Homburger AG (Included in Exhibit 5.2). | |
| | 24.1 | | | | Power of Attorney with respect to Bunge Global SA. | |
| | 24.2 | | | | Power of Attorney with respect to Bunge Limited Finance Corp. | |
| | 25.1 | | | | Form T-1 of U.S. Bank Trust Company, National Association, under the Trust Indenture Act of 1939. | |
| | 99.1 | | | | Form of Letter of Transmittal. | |
| | 107 | | | | Filing Fee Table | |
Financial Officer
|
Signature
|
| |
Title
|
| |
Date
|
|
|
*
Gregory A. Heckman
|
| |
Executive Vice President and Chief Executive
Officer, Director (Principal Executive Officer) |
| |
July 10, 2025
|
|
|
*
John W. Neppl
|
| |
Executive Vice President and Chief Financial
Officer (Principal Financial Officer) |
| |
July 10, 2025
|
|
|
*
J. Matt Simmons, Jr.
|
| |
Controller
(Principal Accounting Officer) |
| |
July 10, 2025
|
|
|
*
Eliane Aleixo Lustosa de Andrade
|
| |
Director
|
| |
July 10, 2025
|
|
|
*
Carol M. Browner
|
| |
Director
|
| |
July 10, 2025
|
|
|
*
Gregory A. Heckman
|
| |
Director
|
| |
July 10, 2025
|
|
|
*
Linda Jojo
|
| |
Director
|
| |
July 10, 2025
|
|
|
*
Monica McGurk
|
| |
Director
|
| |
July 10, 2025
|
|
|
*
Kenneth Simril
|
| |
Director
|
| |
July 10, 2025
|
|
|
Signature
|
| |
Title
|
| |
Date
|
|
|
*
Henry W. (Jay) Winship
|
| |
Director
|
| |
July 10, 2025
|
|
|
*
Mark N. Zenuk
|
| |
Director
|
| |
July 10, 2025
|
|
|
By:
/s/ Lisa Ware-Alexander
Lisa Ware-Alexander, Attorney-in-fact
|
| | July 10, 2025 | |
|
Signature
|
| |
Title
|
| |
Date
|
|
|
*
Rajat Gupta
|
| |
President and Director
|
| |
July 10, 2025
|
|
|
*
John W. Neppl
|
| |
Director
|
| |
July 10, 2025
|
|
|
*
Pratik P. Mohta
|
| |
Treasurer
|
| |
July 10, 2025
|
|
|
*
J. Matt Simmons, Jr.
|
| |
Director
|
| |
July 10, 2025
|
|
|
By:
/s/ Lisa Ware-Alexander
Lisa Ware-Alexander, Attorney-in-fact
|
| | July 10, 2025 | |